Survival Better For Kidney Recipients Taken Off Steroids

May 09, 1997

Weaning kidney transplant recipients off steroids is associated with excellent patient and graft survival, according to results of a study being presented at the ASTP meeting May 11 by Ron Shapiro, M.D., associate professor of surgery at the University of Pittsburgh's Thomas E. Starzl Transplantation Institute. In addition, the study of patients whose immunosuppression was managed with the anti-rejection drug tacrolimus, or Prograf, found the incidence of rejection was much lower in patients who no longer took steroids.

Surgeons routinely prescribe steroids, such as prednisone, in combination with other drugs to help protect a transplanted kidney from being rejected. However, steroids can cause side-effects ranging from weight gain, puffy cheeks and unwanted facial hair to more serious medical complications, such as muscle wasting, diabetes, osteoporosis and susceptibility to infections.

In Dr. Shapiro's study, 289 out of 379 adult kidney patients were taken off prednisone between four and 36 months after receiving transplants from cadaveric or living-related donors. One-year patient survival was 99 percent in the group no longer taking steroids, compared to 91 percent of those still on steroids. At three years, patient survival was 98 and 80 percent, respectively. One- and three-year graft survival was 98 and 94 percent in the patients taken off steroids, compared to 77 and 50 percent in the patients not weaned, in whom there was also a higher incidence of rejection (73 percent). Rejection occurred in 43 percent of those taken off steroids.


University of Pittsburgh Medical Center

Related Steroids Articles from Brightsurf:

Study shows protective role sex steroids play in COVID-19
''Sex and Covid-19: A protective role for reproductive steroids,'' by Graziano Pinna, research associate professor in psychiatry, analyzes existing research to look at reasons why COVID-19 symptom severity and mortality are more frequent in men than in women and in older people.

New RA guideline emphasizes maximizing methotrexate and biologics, minimizing steroids
The American College of Rheumatology (ACR) will preview its 2020 Guideline for the Management of Rheumatoid Arthritis (RA) at ACR Convergence, the ACR's annual meeting.

Microwaves are useful to combine amino acids with hetero-steroids
Aza-steroids are important class of compounds because of their numerous biological activities.

Early steroids improve outcomes in patients with septic shock
Some critically ill patients with septic shock need medications called vasopressors to correct dangerously low blood pressure.

Cumulative doses of oral steroids linked to increased blood pressure
Cumulative doses of oral steroids in patients with chronic inflammatory diseases are associated with increased hypertension (blood pressure) for those who take them regularly, found new research in CMAJ (Canadian Medical Association Journal).

Fewer steroids, no plasma exchange: A change in treatment for vasculitis
The insights from the PEXIVAS Trial, a 10-year study, shows treatment for ANCA-associated vasculitis can use half the standard dosage of steroids and involve no blood plasma exchanges.

Steroids could do more harm than good in treating coronavirus
Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised.

Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

One third of patients with severe asthma are taking harmful doses of oral steroids
A third of patients with severe asthma are taking harmful doses of oral steroids, according to a study of several thousand people in The Netherlands, presented at the European Respiratory Society International Congress.

Oral steroids put patients with inflammatory disease at high risk of infection
Oral steroid use in patients with the inflammatory diseases polymyalgia rheumatica and/or giant cell arteritis significantly increased the risk of infection, and the risk increased with higher doses, found a study in CMAJ (Canadian Medical Association Journal).

Read More: Steroids News and Steroids Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to